BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32398463)

  • 1. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
    Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
    Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
    Dougherty JA; Yarsley RL
    Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
    Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
    Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
    Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
    J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
    Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
    Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
    Warkentin TE
    Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
    [No Abstract]   [Full Text] [Related]  

  • 7. HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia.
    Bauman MMJ; Naylor RM; Wijdicks EF
    J Thromb Thrombolysis; 2021 Oct; 52(3):952-961. PubMed ID: 34089462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
    Gonzales M; Pipalia A; Weil A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
    Irani M; Siegal E; Jella A; Aster R; Padmanabhan A
    Transfusion; 2019 Mar; 59(3):931-934. PubMed ID: 30556588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.
    Onuoha C; Barton KD; Wong ECC; Raval JS; Rollins-Raval MA; Ipe TS; Kiss JE; Boral LI; Adamksi J; Zantek ND; Onwuemene OA
    Transfusion; 2020 Nov; 60(11):2714-2736. PubMed ID: 32812222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient.
    Habibi S; Hsieh TC; Khanna S
    Am J Case Rep; 2023 Dec; 24():e941865. PubMed ID: 38158651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
    Lei BZ; Shatzel JJ; Sendowski M
    Transfusion; 2017 Apr; 57(4):919-923. PubMed ID: 27943368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports.
    Makita N; Ohara T; Tsuji Y; Ueda T; Nakamura T; Mizuno T; Makino M
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107032. PubMed ID: 36701852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Severe Heparin-induced Thrombocytopenia with Intravenous Immunoglobulin, Platelet Transfusion and Rivaroxaban: A Case Report.
    Huang H; Lin Y; Yao RX; He MQ; Lin XJ
    Chin Med Sci J; 2019 Mar; 34(1):60-64. PubMed ID: 30961783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia.
    Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Onwuemene OA
    Thromb Res; 2021 May; 201():6-14. PubMed ID: 33621860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgery.
    Rankin JS; Stratton CW
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):808-13; discussion 813-5. PubMed ID: 24239233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.